Loading...
•
Oct 31, 2022
Cooper Q4 2022 Earnings Report
CooperCompanies reported Q4 2022 results with revenue up 12% year-over-year and EPS down 40%.
Key Takeaways
CooperCompanies announced its Q4 and full year 2022 results, with Q4 revenue increasing by 12% to $848.1 million. GAAP diluted EPS for the quarter was $1.32, a decrease of 40% compared to the previous year. The company closed the fiscal year with record annual revenue driven by gains in contact lenses and fertility.
Fourth quarter revenue increased 12% year-over-year to $848.1 million.
Fourth quarter GAAP diluted earnings per share (EPS) of $1.32, down 40% from last year's fourth quarter.
Fourth quarter Non-GAAP diluted EPS of $2.75, down 16% from last year's fourth quarter.
Free cash flow of $35.8 million.
Cooper
Cooper
Cooper Revenue by Segment
Cooper Revenue by Geographic Location
Revenue by Segment
Office & Surgical Revenue
CapyFin.comFertility Revenue
CapyFin.comRevenue by Geographic Location
Americas Revenue
CapyFin.comEMEA Revenue
CapyFin.comAsia Pacific Revenue
CapyFin.com Forward Guidance
The Company initiated its fiscal year 2023 guidance. Fiscal 2023 total revenue of $3,455 - $3,515 million (organic growth of 6% to 8%). Fiscal 2023 non-GAAP diluted earnings per share of $12.30 - $12.60.
Positive Outlook
- Fiscal 2023 total revenue of $3,455 - $3,515 million (organic growth of 6% to 8%)
- CVI revenue of $2,325 - $2,365 million (organic growth of 7% to 9%)
- CSI revenue of $1,130 - $1,150 million (organic growth of 4% to 6%)
- Fiscal 2023 non-GAAP diluted earnings per share of $12.30 - $12.60
- Focus on delivering market share gains and long-term shareholder value.
Challenges Ahead
- Fiscal year 2023 guidance does not include the Cook Medical Reproductive Health acquisition announced on February 7, 2022, as the transaction is pending regulatory approval.
- Non-GAAP diluted earnings per share guidance excludes amortization and impairment of intangible assets, and other exceptional or unusual income or gains and charges or expenses including acquisition, integration and manufacturing related costs which we may incur as part of our continuing operations.
- The Company has not reconciled non-GAAP diluted earnings per share guidance to GAAP diluted earnings per share due to the inherent difficulty in forecasting acquisition-related, integration and restructuring charges and expenses
- Adverse changes in the global or regional general business, political and economic conditions.
- The effects of the COVID-19 pandemic and related economic disruptions and new governmental regulations on our business, results of operations, cash flow and financial condition
Revenue & Expenses
Visualization of income flow from segment revenue to net income